Venture Capital

True North Therapeutics Announces $45M Series D Financing

by posted 4years ago 2672 views
<p>The Series D round is led by new investors HBM Healthcare Investments and Redmile Group and existing investor Perceptive Advisors, and includes participation by an additional new investor Franklin Templeton Investments, as well as existing investors.</p> <div>&nbsp;</div>